By AuntMinnie.com staff writers

September 12, 2019 -- The U.S. Food and Drug Administration (FDA) has released a final guidance on its Special 510(k) program.

The agency's previous guidance, "The New 510(k) Paradigm: Alternate Approaches to Demonstrating Substantial Equivalence in Premarket Notifications," is replaced by this final document and the Abbreviated 510(k) Program document.

The FDA has also updated the following final guidance documents:

"Together, these guidance documents provide consistency, clarity, and transparency to industry and the FDA and may conserve resources for both, while still protecting public health, and not altering the statutory criteria for substantial equivalence," the agency said.

The FDA is holding a webinar on October 31 to discuss these guidances.


Copyright © 2019 AuntMinnie.com
 
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: